The M&A Financial Risk Research Of THDB Pharmaceutical Corporation To HGSJ Corporation

Nowadays,trans-regional mergers and acquisitions of Chinese enterprises become more and more frequent.In most cases,the familiarity and awareness of the acquirer to merge-market abroad is comparatively poor to domestic market,so there's a higher risk of trans-regional mergers and acquisitions than domestic mergers and acquisition.Therefore,the research to trans-regional mergers and acquisitions risk,especially financial risk becomes particularly important.Financial risk throughout the whole process of enterprises trans-regional mergers and acquisitions,M&A failure cases caused by financial risk becomes increasing pronounced.How to identify,control and prevent trans-region M&A financial risk becomes the primary question of these enterprises.Based on trans-regional M&A financial risk theory,this paper analyse the source of financial risk to the case of THDB Pharmaceutical Corporation acquired HGSJ Corporation,and presents the trans-regional M&A financial risk precautionary measures and commendations from THDB Pharmaceutical Corporation's viewpoint.The first part,introduction,presents the research significance and background of this thesis.The second part presents the research basis,mainly states the identification and types of trans-regional M&A.The mainly financial risk of trans-regional M&A includes value evaluation risk,financing risk,payment risk and financial conformity risk,and through the analysis of financial risk genesis,it could strengthen risk prevention and control.The third part presents relative background and driver analysis of THDB Pharmaceutical Corporation acquired HGSJ Corporation.The forth part presents the M&A financial risk of THDB pharmaceutical corporation and HGSJ Corporation.The fifth part presents the following financial risk prevention of THDB pharmaceutical corporation.